Increased intracranial pressure (ICP) refers to abnormally high pressure inside the skull. The skull is a rigid, closed structure containing three major components: brain tissue (80%), cerebrospinal fluid (CSF, 10%), and blood (10%). These components must remain in balance to keep pressure stable, a principle known as the Monro-Kellie doctrine. When the volume of one component rises without a corresponding decrease in another, intracranial pressure increases. Elevated ICP can lead to brain injury, herniation, or even death. Normal ICP in a resting adult is 7–15 mmHg, while sustained pressures above 20 mmHg require urgent medical intervention. Increased ICP is not a disease itself but rather a manifestation of an underlying condition that needs immediate recognition and management.

Increased ICP occurs when the balance of brain tissue, CSF, and blood volume inside the skull is disrupted. Because the skull cannot expand, even small changes in volume can cause significant pressure rises. Elevated ICP can develop suddenly (acute) after trauma or bleeding, or gradually (chronic) due to conditions such as tumors or hydrocephalus. Regardless of the cause, raised ICP poses a life-threatening risk by reducing blood flow to the brain and increasing the likelihood of herniation, where brain tissue shifts from one compartment to another. Understanding increased ICP is critical because early detection and treatment can prevent permanent neurological damage.

Multiple conditions can increase ICP by raising the volume of brain tissue, CSF, or blood inside the skull. These causes are often grouped into categories based on the mechanism of pressure rise.

• Mass lesions: Tumors, abscesses, hematomas (epidural, subdural, intracerebral), aneurysms, and arteriovenous malformations add extra volume that compresses surrounding tissue.
• Cerebral edema: Brain swelling occurs after trauma, stroke, infections (meningitis, encephalitis), hypertensive encephalopathy, liver failure, or toxic-metabolic disturbances.
• Increased CSF volume: Hydrocephalus, choroid plexus tumors, or impaired CSF absorption due to scarring or hemorrhage can elevate pressure.
• Increased cerebral blood volume: Causes include venous outflow obstruction (e.g., jugular vein thrombosis), hypercapnia (high CO₂), seizures, or congestive heart failure.
• Idiopathic intracranial hypertension (IIH): Most common in young obese women, IIH mimics brain tumors but has no visible lesion.
• Drug-induced intracranial hypertension: Certain medications (vitamin A derivatives, tetracyclines, growth hormone, some antibiotics) can elevate ICP. Stopping the offending drug often resolves symptoms.

Risk factors include head trauma, stroke, infections, tumors, congenital malformations, and obesity. Recognizing these risks allows for early diagnosis and treatment.

The body normally compensates for small changes in intracranial volume by shifting CSF, altering blood flow, or reducing CSF production. When these mechanisms are overwhelmed, ICP rises sharply. The process typically progresses in stages:

1. Primary insult: An event such as trauma, stroke, or tumor disrupts normal intracranial dynamics.
2. Compensation: CSF is displaced, venous blood volume decreases, and CSF production may be reduced to stabilize pressure.
3. Decompensation: Compensatory mechanisms fail, causing ICP to rise steeply.
4. Cerebral ischemia: High ICP lowers cerebral perfusion pressure (CPP), restricting oxygen and nutrient delivery to brain tissue.
5. Herniation: Severe pressure forces brain tissue to shift, compressing the brainstem and potentially leading to coma or death.

Raised ICP is a common complication of severe neurological illness and trauma. It is frequently seen in patients with traumatic brain injury, stroke, brain tumors, and CNS infections. Idiopathic intracranial hypertension is more prevalent in women of childbearing age who are overweight or obese. Because ICP can develop from many underlying conditions, its true incidence is difficult to measure, but it is a frequent cause of admission to intensive care units worldwide.

The presentation of ICP varies depending on how quickly pressure rises, the underlying cause, and patient age. Early recognition of symptoms is crucial to prevent irreversible damage.

• Headache: Often worse in the morning or when coughing, straining, or lying flat.
• Nausea and vomiting: Frequently sudden and forceful, due to stimulation of the brain’s vomiting center.
• Altered mental status: Ranging from confusion and restlessness to drowsiness, stupor, or coma.
• Visual disturbances: Blurred or double vision, papilledema (optic disc swelling), transient vision loss, or sixth nerve palsy.
• Cushing’s triad: Hypertension, bradycardia, and irregular breathing—an ominous sign of brainstem compression.
• Seizures: May occur from cortical irritation, especially with tumors, bleeding, or infections.
• Focal neurological deficits: Weakness on one side, speech problems, or cranial nerve palsies.
• Infants and children: Bulging fontanelle, increasing head size, irritability, poor feeding, lethargy, and downward eye gaze (sunsetting eyes).

Early diagnosis of increased intracranial pressure is essential to reduce the chances of long-term brain damage or death. Doctors begin by carefully evaluating symptoms and performing a neurological examination to look for early warning signs. Imaging tests such as CT or MRI scans can help identify the cause, while monitoring devices may be used in intensive care to measure ICP directly. This combined approach allows for rapid confirmation of elevated pressure and timely initiation of treatment.

• Neurological assessment: Includes Glasgow Coma Scale, pupillary reactivity, motor responses, and fundoscopic exam for papilledema.
• Neuroimaging: CT scans are rapid and effective for identifying mass lesions, hydrocephalus, or hemorrhage. MRI offers more detailed imaging of subtle lesions, posterior fossa abnormalities, and diffuse brain swelling.
• ICP monitoring: In intensive care, devices such as intraventricular catheters (gold standard), subarachnoid bolts, or parenchymal sensors measure ICP directly. Some allow CSF drainage as well as monitoring.
• Lumbar puncture: Can measure CSF opening pressure in cases like IIH, but is contraindicated if mass lesions or hydrocephalus are suspected due to herniation risk.
• Other tests: Blood work to identify infections or metabolic derangements, EEG for seizure activity, and ophthalmological exams for papilledema or visual field loss.

Differential diagnosis for Increased Intracranial Pressure

Increased ICP shares features with many neurological disorders, so careful evaluation is required. Differential diagnoses include:

• Migraine or tension headaches
• Intracranial infections without raised ICP
• Stroke or transient ischemic attack
• Pseudotumor cerebri vs. true brain tumors
• Hypertensive encephalopathy

Management aims to reduce ICP, maintain adequate cerebral blood flow, and treat the underlying cause. Patients are usually treated in intensive care with close monitoring.

• Initial stabilization: Airway, breathing, and circulation support; head elevation; avoidance of neck vein compression; adequate oxygenation; controlled CO₂ levels; and blood pressure management to preserve cerebral perfusion pressure.
• Osmotherapy: Mannitol and hypertonic saline are used to draw fluid out of brain tissue and reduce swelling.
• Sedation and analgesia: Medications like propofol, fentanyl, or midazolam reduce agitation, pain, and metabolic demand.
• Controlled ventilation: Temporary hyperventilation may lower ICP by reducing CO₂ and causing cerebral vasoconstriction, used only in emergencies.
• CSF drainage: Ventriculostomy allows monitoring and removal of CSF, especially useful in hydrocephalus or intraventricular bleeding.
• Surgical decompression: Craniotomy or decompressive craniectomy may be performed when medical therapy fails. Tumor removal, hematoma evacuation, or shunt placement may be needed.
• Corticosteroids: Helpful for vasogenic edema from brain tumors, but not indicated in trauma-related ICP.
• Treating the cause: Antibiotics or antivirals for infections, antiepileptics for seizures, weight loss and acetazolamide for IIH, or vascular surgery for aneurysms and clots.

If untreated, raised ICP can cause devastating outcomes that affect both survival and long-term quality of life. Complications may involve damage to vital brain structures, long-lasting neurological deficits, or even sudden death in the most severe cases. Potential complications include:

• Brain herniation, where brain tissue shifts and compresses critical structures
• Stroke or permanent brain damage from ischemia due to reduced blood flow
• Chronic seizures, sometimes evolving into epilepsy that requires lifelong treatment
• Vision loss from prolonged papilledema or damage to the optic nerve
• Cognitive and functional impairments, including difficulties with memory, concentration, or motor coordination
• Personality or behavioral changes that can interfere with daily life and independence
• Increased vulnerability to secondary complications such as infections or further strokes

The outlook depends on the cause, severity, and speed of treatment. Prompt intervention can lead to recovery, especially when the underlying cause is reversible. However, delayed treatment increases the risk of death or permanent disability. Survivors may face long-term neurological problems, particularly after traumatic brain injury or large strokes. Careful rehabilitation and follow-up are crucial for improving quality of life.

While not all cases of ICP can be prevented, risk can be reduced by managing underlying conditions:

• Preventing head trauma through seatbelts, helmets, and fall precautions
• Controlling hypertension and cardiovascular disease
• Managing obesity to reduce risk of IIH
• Seeking prompt treatment for infections
• Careful use of medications known to raise ICP

Living with or recovering from ICP often involves ongoing neurological care. Patients may need physical, occupational, or speech therapy to regain function. Regular eye exams are important for monitoring vision changes. Emotional support and counseling help patients and families adjust to long-term effects. Education about warning signs and careful follow-up with healthcare providers can reduce recurrence and improve outcomes.

Increased intracranial pressure is a life-threatening condition caused by disruptions in the balance of brain tissue, CSF, and blood within the skull. It arises from many underlying conditions, including trauma, tumors, infection, and fluid disturbances. Recognizing early warning signs such as headaches, confusion, and visual changes is critical to prevent progression to herniation and death. Management requires urgent medical care, often in intensive care settings, using both medical and surgical treatments tailored to the cause. With early diagnosis, appropriate intervention, and rehabilitation, many patients recover and achieve good quality of life.

1. Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.
2. Ropper AH, Samuels MA. Adams and Victor’s Principles of Neurology. 11th ed. McGraw-Hill Education; 2019.
3. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.
4. Sonnenberg A. Historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38(4):329–342.